The five year Sixth Community Pharmacy Agreement (6CPA) between the Commonwealth of Australia and the Pharmacy Guild of Australia commenced on 1 July 2015 and is a key element of the PBS Access and Sustainability Package, announced in the 2015-16 Budget. Further information about the 6CPA can be found on the PBS website
The MedsCheck/Diabetes MedsCheck Program provides for in-pharmacy reviews of consumers who are taking multiple medications and/or have newly diagnosed or poorly controlled Type 2 diabetes. These reviews are aimed at enhancing the quality use of medicines and reducing the number of adverse drug events experienced by consumers.
MedsCheck is an in-pharmacy, consumer centred service which aims to enhance the quality use of medicines by:
- educating community based consumers about their medicines including how medicines affect medical conditions;
- identifying any problems they may be experiencing with their medicines; and
- understanding interactions between medicines.
is an in-pharmacy, consumer centred service. The service provides a review of medications with a focus on the consumer’s type 2 diabetes medication management, their monitoring devices and self-management and where the consumer has no timely access to other diabetes health services. It aims to:
What do I need to do to provide the MedsCheck service?
- optimise a consumer’s effective use of medicine through improving understanding of, and compliance with, their diabetes medication therapy;
- improve a consumer’s effective use of blood glucose monitoring devices through training and education; and
- reduce the risk of the consumer developing complications associated with type 2 diabetes.
From 1 March 2014, the Pharmacy Guild of Australia will process applications and claims for payments for the RMMR Programme. For further information, please visit the 5CPA website